Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis

Cancer Cell

Volumn 1, Issue 4, 2002, Pages 339-353

  Lopez, Theresa ^a   Hanahan, Douglas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN RECEPTOR; UVOMORULIN; VIRUS LARGE T ANTIGEN; BETA GLUCOSIDASE; BROXURIDINE; CADHERIN; DIAGNOSTIC AGENT; DNA BINDING PROTEIN; IGHMBP2 PROTEIN, HUMAN; IGHMBP2 PROTEIN, MOUSE; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR;

ANGIOGENESIS; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM DYSPLASIA; LYMPH NODE METASTASIS; NONHUMAN; PANCREAS ISLET CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; C57BL MOUSE; CELL DIVISION; DISEASE COURSE; FLOW CYTOMETRY; GENETICS; HUMAN; METABOLISM; METASTASIS; MOUSE; NICK END LABELING; PANCREAS TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

MUS MUSCULUS;

ANIMALS; APOPTOSIS; BETA-GLUCOSIDASE; BLOTTING, WESTERN; BROMODEOXYURIDINE; CADHERINS; CARCINOMA, ISLET CELL; CELL DIVISION; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 0036559535     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00055-7     Document Type: Article

References (64)

1. Alpert, S., Hanahan, D., and Teitelman, G. (1988). Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons. Cell 53, 295-308.
2. Andre, F., Rigot, C., Thimonier, J., Montixi, C., Parat, F., Pommier, G., Marvaldi, J., and Luis, J. (1999). Integrins and E-cadherin cooperate with IGF-I to induce migration of epithelial colonic cells. Int. J. Cancer 83, 497-505.
3. Baserga, R., Hongo, A., Rubini, M., Prisco, M., and Valentinis, B. (1997). The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta 1332, F105-F126.
4. Bergers, G., Hanahan, D., and Coussens, L.M. (1998). Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic tumor models of tumorigenesis. Int. J. Dev. Biol. 42, 995-1002.
5. Bergers, G., Javaharian, K., Folkman, J., and Hanahan, D. (1999). Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284, 808-812.
6. Bergers, G., Brekken, R., McMahon, J., Vu, T., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., and Hanahan, D. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737-744.
7. Braulke, T. (1999). Type-2 IGF receptor: a multi-ligand binding protein. Horm. Metab. Res. 31, 242-246.
8. Brodt, P., Fallavollita, L., Khatib, A.-M., Samini, A.A., and Zhang, D. (2001). Cooperative regulation of the invasive and metastatic phenotypes by different domains of the type I insulin-like growth factor receptor β subunit. J. Biol. Chem. 276, 33608-33615.
9. Cavallaro, U., and Christofori, G. (2001). Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim. Biophys. Acta 1552, 39-45.
10. Christofori, G., and Semb, H. (1999). The role of the cell-adhesion molecule E-cadherin as a tumor-suppressor gene. Trends Biochem. Sci. 24, 73-76.
11. Christofori, G., Naik, P., and Hanahan, D. (1994). A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369, 414-418.
12. Christofori, G., Naik, P., and Hanahan, D. (1995). Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during β-cell tumorigenesis. Nat. Genet. 10, 196-201.
13. Comoglio, P.M., Tamagnone, L., and Boccaccio, C. (1999). Plasminogen-related growth factor and semaphorin receptors: a gene superfamily controlling invasive growth. Exp. Cell Res. 253, 88-99.
14. Cook, M. (1983). Anatomy. In The Mouse in Biomedical Research, H.L. Foster, J. David Small, J.G. Fox, eds. (New York: Academic Press), pp.110-113.
15. Cook, S., Aziz, N., and McMahon, M. (1999). The repertoire of Fos and Jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol. Cell. Biol. 19, 330-341.
16. DeChiara, T.M., Robertson, E.J., and Efstratiadis, A. (1991). Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64, 849-859.
17. Dunn, S.E., Ehrlich, M., Sharp, J.H., Reiss, K., Solomon, G., Hawkins, R., Baserga, R., and Barrett, J.C. (1998). A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res. 58, 3353-3361.
18. Dunn, S.E., Torres, J.V., Oh, J.S., Cykert, D.M., and Barrett, J.C. (2001). Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase. Cancer Res. 61, 1367-1374.
19. Dupont, J., and LeRoith, D. (2001). Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. Horm. Res. 55 (Suppl 2), 22-26.
20. Efrat, S., Linde, S., Kofod, H., Spector, D., Delannoy, M., Grant, S., Hanahan, D., and Baekkeskov, S. (1988). β cell lines derived from transgenic mice expressing a hybrid insulin oncogene. Proc. Natl. Acad. Sci. USA 85, 9037-9041.
21. Evan, G., and Littlewood, T. (1998). A matter of life and death. Science 281, 1317-1322.
22. Ferguson-Smith, A.C., Cattanach, B.M., Barton, S.C., Beechey, C.V., and Surani, M.A. (1991). Embryological and molecular investigations of parental imprinting on mouse chromosome 7. Nature 351, 667-670.
23. Folkman, J., and Hanahan, D. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
24. Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Constantino, A., Goldfine, I.D., Belfiore, A., and Vigneri, R. (1999). Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol. Cell. Biol. 5, 3278-3288.
25. Furge, K.A., Zhang, Y.W., and Vande Woude, G.F. (2000). Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene 49, 5582-5589.
26. Grant, S.N.G., Seidman, I., Hanahan, D., and Bautch, V.L. (1991). Early invasiveness characterizes metastatic carcinoid tumors in transgenic mice. Cancer Res. 51, 4917-4923.
27. Grewal, A., Bradshaw, S.L., Schuller, A.G., Low, M.J., and Pintar, J.E. (1999). Expression of IGF system genes during T-antigen driven pituitary tumorigenesis. Horm. Metab. Res. 31, 155-160.
28. Grimberg, A., and Cohen, P. (2000). Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J. Cell. Physiol. 183, 1-9.
29. Grothey, A., Voigt, W., Schober, C., Muller, T., Dempke, W., and Schmoll, H.J. (1999). The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors. J. Cancer Res. Clin. Oncol. 125, 166-173.
30. Hager, J.H., and Hanahan, D. (1999). Tumor cells utilize multiple pathways to down-modulate apoptosis: lessons from a mouse model of islet cell carcinogenesis. Ann. NY Acad. Sci. 887, 150-163.
31. Hanahan, D. (1985). Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315, 115-122.
32. Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57-70.
33. Harrington, E.A., Bennet, M.R., Fanidi, A., and Evan, G.I. (1994). c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 14, 3286-3295.
34. Hiscox, S., and Jiang, W.G. (1999). Association of the HGF-SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells. Biochem. Biophys. Res. Commun. 261, 406-411.
35. r 72,000 type IV collagenase by the type I insulin-like growth factor receptor. Cancer Res. 58, 3243-3247.
36. Long, L., Rubin, R., and Brodt, P. (1998b). Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor. Exp. Cell Res. 238, 116-121.
37. Ludlow, J.W. (1993). Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53. FASEB J. 7, 866-871.
38. Macaulay, V.M. (1992). Insulin-like growth factors and cancer. Br. J. Cancer 65, 311-320.
39. Mandriota, S.J., Jussila, L., Jeltsch, M., Compagni, A., Baetens, D., Prevo, R., Banerji, S., Huarte, J., Montesano, R., Jackson, D.G., et al. (2001). Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumor metastasis. EMBO J. 20, 672-682.
40. Mira, E., Manes, S., Lacalle, R.A., Marquez, G., and Martinez, A.C. (1999). Insulin-like growth factor I-triggered cell migration and invasion are mediated by matrix metalloproteinase-9. Endocrinology 140, 1657-1664.
41. Naik, P. (1996). The regulation and role of cell survival and cell death in multistage tumorigenesis. PhD thesis, University of California, San Francisco, San Francisco, California.
42. Naik, P., Christofori, G., and Hanahan, D. (1994). Insulin-like growth factor II is focally up-regulated and functionally involved as a second signal for oncogene-induced tumorigenesis. Cold Spring Harb. Symp. Quant. Biol. 59, 459-470.
43. Naik, P., Karrim, J., and Hanahan, D. (1996). The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev. 10, 2105-2116.
44. Nakae, J., Kido, Y., and Accili, D. (2001). Distinct and overlapping functions of insulin and IGF-I receptors. Endocr. Rev. 22, 818-835.
45. Noe, V., Chastre, E., Bruyneel, E., Gespach, C., and Mareel, M. (1999). Extracellular regulation of cancer invasion: the E-cadherin-catenin and other pathways. Biochem. Soc. Symp. 65, 43-62.
46. Pandini, G., Vigneri, R., Constantitno, A., Frasca, F., Ippolito, A., Fujita-Yamaguchi, Y., Siddle, K., Goldfine, I.D., and Belfiore, A. (1999). Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-signaling. Clin. Cancer Res. 7, 1935-1944.
47. Perl, A.-K., Wilgenbus, P., Dahl, U., Semb, H., and Christofori, G. (1998). A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392, 190-193.
48. Perl, A.-K., Dahl, U., Wilgenbus, P., Cremer, H., Semb, H., and Christofori, G. (1999). Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic β tumor cells. Nat. Med. 3, 286-291.
49. Playford, M.P., Bicknell, D., Bodner, W.F., and Macaulay, V.M. (2000). Insulin-like growth factor 1 regulates the location, stability and transcriptional activity of β catenin. Proc. Natl. Acad. Sci. USA 97, 12103-12108.
50. Quinn, K.A., Treston, A.M., Unsworth, E.J., Miller, M.J.-J., Vos, M., Grimley, C., Battery, J., Mulshine, J.L., and Cuttita, F. (1996). Insulin-like growth factor expression in human cancer cell lines. J. Biol. Chem. 271, 11477-114833.
51. Rappolee, D.A., Sturm, K.S., Behrendtsen, O., Schultz, G.A., Pederson, R.A., and Werb, A. (1992). Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. Genes Dev. 6, 939-952.
52. Scharf, J.G., Dombrowski, F., and Ramadori, G. (2001). The IGF axis and hepatocarcinogenesis. Mol. Pathol. 54, 138-144.
53. Sell, C., Rubini, M., Rubin, R., Liu, J.-P., Efstratiadis, A., and Baserga, R. (1993). Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc. Natl. Acad. Sci. USA 90, 11217-11221.
54. Stewart, C.E., and Rotwein, P. (1996). Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol. Rev. 76, 1005-1026.
55. Tuttle, R.L., Gill, N.S., Pugh, W., Lee, J.-P., Koeberlein, B., Furth, E.E., Polonsky, K.S., Naji, A., and Birnbaum, M.J. (2001). Regulation of pancreatic β cell size and function by the serine/threonine protein kinase Akt/PKB. Nat. Med. 10, 1133-1137.
56. Ullrich, A., Gray, A., Tam, A.W., Yang-Feng, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Kathuria, S., and Chen, E. (1986). Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5, 2503-2512.
57. Vella, V., Pandini, G., Sciacca, L., Mineo, R., Vigneri, R., Pezzino, V., and Belfiore, A. (2002). A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J. Clin. Endocrinol. Metab. 87, 245-254.
58. Wang, R., Ferrel, L.D., Faouzi, S., Maher, J.J., and Bishop, J.M. (2001). Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J. Cell Biol. 153, 1023-1034.
59. Werner, H., and Leroith, D. (1996). The role of the insulin-like growth factor system in human cancer. Adv. Cancer Res. 68, 183-223.
60. Werner, H., Karnieli, E., Rauscher, F.J., and LeRoith, D. (1996). Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc. Natl. Acad. Sci. USA 93, 8318-8323.
61. Cip1. Mol. Cell. Biol. 17, 5598-5611.
62. Xie, Y., Skytting, B., Nilson, G., Brodin, B., and Larsson, O. (1999). Expression of insulin-like growth factor-1 receptor in synovial sarcoma: association with an aggressive phenotype. Cancer Res. 59, 3588-3591.
63. Yamasaki, H., Prager, D., Gebremedhin, S., and Melmed, S. (1991). Insulin-like growth factor-1 (IGF-1) attenuation of growth hormone is enhanced by overexpression of pituitary IGF-1 receptors. Mol. Endocrinol. 5, 890-896.
64. Zhou-Li, F., D'Ambrosio, C., Li, S., Surmacz, E., and Baserga, R. (1995). Association of insulin receptor substrate 1 with simian virus 40 large T antigen. Mol. Cell. Biol. 15, 4232-4239.